OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Els Fieremans

2 Projects | 1 Researchers | $261,284 Invested

2013

New York University

Els Fieremans, PhD

White matter involvement in preclinical AD: a multimodal MR-PET study

  • Funding Amount: $200,184
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2011

New York University

Els Fieremans, PhD

Axonal Density as a Non-Invasive Biomarker for the Early Prediction and Monitoring of Alzheimer's Disease: an MRI Pilot Study

  • Funding Amount: $61,100
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed